Meeting
2022 ASCO Annual Meeting
Genomic alterations and evolution in patients with prostate cancer with histologic evidence of neuroendocrine differentiation.
Authors
Ethan Barnett
Memorial Sloan Kettering Cancer Center, New York, NY
Ethan Barnett , Emily Carbone , Niamh M. Keegan , Samantha E Vasselman , Barbara Nweji , Samir Zaidi , Howard I. Scher
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5029)
DOI
10.1200/JCO.2022.40.16_suppl.5029
Abstract #
5029
Poster Bd #
213
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer.
First Author: Samir Zaidi
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.
First Author: Aishwarya Subramanian
Poster
2023 ASCO Annual Meeting
Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.
First Author: Edward Christopher Dee
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer.
First Author: Philip Sutera